While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...

The biotech, which has for years invested in genetics research, plans to acquire "substantially all" of testing firm ...

As the NMPA joins the EU and the U.S. in placing sterility assurance and contamination control front and center, ...